Green Health & Wellness Most patients using weight-loss drugs like Wegovy stop within a year, data show – GWC Mag gwcmagOctober 7, 2023037 views Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article Tags Topics of Interest: Health Type: Reuters Best Sectors: Pharmaceuticals & Healthcare Regions: Americas Countries: United States Win Types: Exclusivity Story Types: Exclusive / Scoop Media Types: Text Customer Impact: Significant National Story